Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response

T Fu, LJ Dai, SY Wu, Y ** of the tumor and peripheral blood immune landscape in human pancreatic cancer
NG Steele, ES Carpenter, SB Kemp, VR Sirihorachai… - Nature cancer, 2020 - nature.com
Pancreatic ductal adenocarcinoma (PDA) is characterized by an immune-suppressive tumor
microenvironment that renders it largely refractory to immunotherapy. We implemented a …

Regulatory T-cell depletion alters the tumor microenvironment and accelerates pancreatic carcinogenesis

Y Zhang, J Lazarus, NG Steele, W Yan, HJ Lee… - Cancer …, 2020 - aacrjournals.org
Regulatory T cells (Treg) are abundant in human and mouse pancreatic cancer. To
understand the contribution to the immunosuppressive microenvironment, we depleted …

[HTML][HTML] Macrophage-released pyrimidines inhibit gemcitabine therapy in pancreatic cancer

CJ Halbrook, C Pontious, I Kovalenko, L Lapienyte… - Cell metabolism, 2019 - cell.com
Pancreatic ductal adenocarcinoma (PDA) is characterized by abundant infiltration of tumor-
associated macrophages (TAMs). TAMs have been reported to drive resistance to …

Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal …

Y Liu, SY Ye, S He, DM Chi, XZ Wang, YF Wen… - Nature …, 2024 - nature.com
Tertiary lymphoid structures are immune cell aggregates linked with cancer outcomes, but
their interactions with tumour cell aggregates are unclear. Using nasopharyngeal carcinoma …

Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From bench to bedside

DY Lizardo, C Kuang, S Hao, J Yu, Y Huang… - Biochimica et Biophysica …, 2020 - Elsevier
Colorectal cancers (CRCs) with deficient mismatch repair (dMMR) or microsatellite instability-
high (MSI-H) often have sustained responses to immune checkpoint inhibitors (ICIs) …

[HTML][HTML] Molecular cartography uncovers evolutionary and microenvironmental dynamics in sporadic colorectal tumors

CN Heiser, AJ Simmons, F Revetta, ET McKinley… - Cell, 2023 - cell.com
Colorectal cancer exhibits dynamic cellular and genetic heterogeneity during progression
from precursor lesions toward malignancy. Analysis of spatial multi-omic data from 31 …

Inhibition of ATM increases interferon signaling and sensitizes pancreatic cancer to immune checkpoint blockade therapy

Q Zhang, MD Green, X Lang, J Lazarus… - Cancer …, 2019 - aacrjournals.org
Combinatorial strategies are needed to overcome the resistance of pancreatic cancer to
immune checkpoint blockade (ICB). DNA damage activates the innate immune response …

Hydrogen sulfide creates a favorable immune microenvironment for colon cancer

T Yue, J Li, J Zhu, S Zuo, X Wang, Y Liu, J Liu… - Cancer …, 2023 - aacrjournals.org
Immunotherapy can elicit robust anticancer responses in the clinic. However, a large
proportion of patients with colorectal cancer do not benefit from treatment. Although previous …